Differential effects of oral and intravenous L-carnitine on serum lipids: Is the microbiota the answer?

Clinical Kidney Journal

Volumn 7, Issue 5, 2014, Pages 437-441

  Sanchez Niño, Maria Dolores ^a,b   Ortiz, Alberto ^b,c,d,e  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b REDINREN   (Spain)

^c 28400 Madrid   (Spain)

^d IRSIN   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Carnitine; Chronic kidney disease; Hemodialysis; Trimethylamine N oxide (TMAO)

Indexed keywords

CARNITINE; LIPID;

AMINO ACID BLOOD LEVEL; ANEMIA; CARNITINE DEFICIENCY; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); HEMODIALYSIS; HUMAN; HYPOTENSION; LIPID BLOOD LEVEL; META ANALYSIS (TOPIC); MICROFLORA; NOTE; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC);

EID: 84986877721     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfu099     Document Type: Note

References (0)